Atrium Mortgage Invest Balances Growth and Credit Risks

Atrium Mortgage Invest ((TSE:AI)) has held its Q4 earnings call. Read on for the main highlights of the call.

Atrium Mortgage Invest’s latest earnings call struck a cautiously upbeat tone, with modest profit growth, a special dividend, and lower funding costs offset by rising impaired loans and a soft housing market. Management emphasized strong liquidity and conservative underwriting as key defenses in what they described as a challenging and uncertain macro backdrop.

Steady Earnings Growth and Dividend Coverage

Atrium posted 2025 net income of $49.1 million, up 2.5% year over year, with basic EPS of $1.03 comfortably covering its fixed dividend of $0.93. The company highlighted that earnings growth, while modest, demonstrates resilience in a tough market and supports its strategy of maintaining an attractive yield for income-focused investors.

Q4 Profitability and One-Time Payout

Fourth-quarter net income came in at $12.2 million, with EPS of $0.25, down from $0.27 a year earlier as margin pressure and higher impairments weighed on results. Even so, management declared a $0.10 per share special dividend, bringing total 2025 dividends to $1.03 per share and aligning shareholder payouts directly with full-year earnings.

Moderate Portfolio Expansion

The mortgage portfolio finished 2025 at $917.1 million, a 3.4% increase from $886.7 million a year earlier, reflecting cautious growth rather than aggressive balance sheet expansion. Advances of $358.6 million outpaced repayments of $316.6 million, suggesting Atrium is still able to find selective lending opportunities despite subdued market activity.

Lower Funding Costs and Strong Liquidity

Atrium’s weighted average borrowing cost on its credit facility dropped to 5.08% from 7.03% last year, giving the lender a welcome boost to net interest margins. Debt remains conservative at 40% of the balance sheet, with $283 million drawn on a $380 million facility that was upsized during the year and supported by three new lending partners.

Conservative Underwriting and High-Quality Collateral

Management underscored the portfolio’s defensive profile, noting that 95.2% of mortgages are first liens and average LTV is 61.4%, slightly better than last year and within target. Portfolio turnover of roughly 39%, with $317 million of repayments, points to solid liquidity and the ability to recycle capital into higher-quality or better-priced loans.

Shift Toward Lower-Risk Asset Mix

Atrium continued pivoting toward lower-risk segments, with commercial loans rising to 28.7% of the book, a 38% increase or $72 million year over year. Single-family and apartment exposure climbed to 19.2%, bringing these two focus areas to nearly half of the portfolio and signaling a move away from higher-risk residential development lending.

Stable Credit Loss Coverage

The allowance for credit losses increased modestly to $30.5 million, up 3.1% and equivalent to 332 basis points of the mortgage portfolio, essentially flat versus last year. Provision expense for 2025 totaled $4.5 million, which management framed as a reasonable cost of risk given macro headwinds and the rise in impaired balances.

Proactive Balance Sheet De-Risking

Atrium repaid two convertible debentures with principal balances of $28.7 million and $34.4 million during 2025, trimming structural leverage and interest obligations. While the company retains the option to tap the convertible market again in 2026, management stressed that such issuance would be opportunistic and dependent on attractive pricing.

Operational Scaling and Underwriting Capacity

The underwriting team has more than doubled in size since 2020, with two new underwriters added in Toronto and plans to expand in Western Canada. This expanded bench is aimed at improving credit selection and allowing Atrium to capture select lending opportunities, even as overall deal flow remains constrained.

Expected Recovery of a Large Impaired Loan

Management highlighted a $31 million Stage 3 loan that is currently under contract and expected to be repaid in early Q2 2026, a key catalyst for improving credit metrics. Successful recovery would significantly reduce the current stock of impaired loans and free up capital for redeployment into higher-yielding, lower-risk opportunities.

Q4 EPS Pressure Despite Solid Year

Despite a sound full-year performance, Q4 EPS slipped to $0.25 from $0.27, a roughly 7.4% decline year over year. The quarter underscored how rising impairments and competitive pressures can weigh on short-term profitability, even when the broader annual trend remains positive.

Spike in Stage 3 Impaired Loans

Stage 3 loans surged to $86.0 million at year-end from $29.0 million a year earlier and $56.3 million at the end of Q3, an almost threefold increase. This jump was driven largely by three commercial loans totaling about $53 million migrating to Stage 3 in Q4, concentrating risk in a handful of problem files.

Higher Reserves for Impaired Exposures

The allowance specifically for Stage 3 loans rose to $21.5 million from $13.3 million, reflecting a more cautious stance toward impaired assets. While this heavier provisioning hits current earnings, management argued it strengthens the balance sheet and provides a buffer if recoveries take longer than expected.

Weakness Across Key Residential Markets

Residential housing markets remained under pressure, with resale volumes down 11% in the Greater Toronto Area and 10% in Greater Vancouver. Benchmark home prices fell about 6.3% in the GTA and 4.5% in the GVA over 2025, weighing on borrower confidence and transaction activity.

Severe Slowdown in New Homes and Condos

New home sales were deeply depressed versus 10-year averages, down 81% in the GTA and 70% in the GVA, with the condo segment the weakest. Elevated recent supply and sluggish demand are creating near-term headwinds for residential and condo lending, reinforcing Atrium’s pivot toward more stable, income-producing projects.

Concentration Risk in High-Ratio Loans

High-ratio loans above 75% LTV totaled $85 million, or 9.3% of the portfolio, including five concentrated commercial positions totaling $54.7 million. Management noted one $14.25 million loan was repaid in January and another $12.6 million credit is expected to be paid down by the end of March, gradually reducing this pocket of risk.

Provisioning Outlook Remains Uncertain

Looking ahead, management cautioned that credit provisioning for 2026 is difficult to forecast and will likely land near 2025’s $4.5 million level. They do not anticipate a return to the more than $10 million of provisions seen in 2023 but acknowledged that early-year visibility remains limited amid shifting economic conditions.

Challenges in Sourcing New Loans

Atrium reported that finding attractive new lending opportunities in 2026 has been challenging, given subdued transaction volumes and aggressive bank pricing. This combination could cap near-term portfolio growth, even as the company has ample capital and underwriting capacity to deploy when risk-adjusted returns improve.

Macroeconomic and Leverage Trends

Management pointed to a sluggish macro backdrop, with the central bank projecting flat growth in late 2025 and only modest GDP expansion through 2027. The average portfolio LTV ticked up from 60.8% in Q3 to 61.4% at year-end, indicating slightly higher leverage but still consistent with Atrium’s conservative risk appetite.

Forward Guidance and Strategic Priorities

Guidance for 2026 was cautious but constructive, with management expecting provisions similar to 2025’s $4.5 million and well below 2023 levels, while they re-risk-rate every loan each quarter. They plan to prioritize income-producing commercial and single-family lending supported by a liquid, well-capitalized balance sheet, lower funding costs, and the anticipated repayment of key Stage 3 exposures.

Atrium Mortgage Invest’s earnings call portrayed a lender balancing modest growth and shareholder payouts against mounting credit and macro risks. With strong liquidity, disciplined underwriting, and a deliberate shift toward lower-risk assets, the company appears positioned to weather a difficult market, though investors will be watching impaired loan trends and new business growth closely in 2026.